Cytori (CYTX) Q3/11 Results
A net loss of $8.335M or $0.15 per share
CYTX’s Q3/11 product revenues increased to $2.1M, compared to $1.5M in Q3/10. Development revenues were $5K. Cost of product revenue was $942K. Q3/11 gross profit increased to $1.2M with a gross margin of 56%, compared to a gross profit of $0.6M and a gross margin of 39% in Q3/10.
R&D logged in at $2.83M while S&M was $3.618M and G&A was $3.538M. Total operating expenses were $9.02M with an operating loss of $7.823M. Other income was $3K, interest expense was $489K, other income (expense) net was $25K and a loss from JV $51K. Net cash used in operating activities improved to $7.9M from $9M in Q2/11.
Operating expenses, excluding related to the change in the fair value of the warrant and option liabilities were $10M compared with $10.9M in Q2/11. Basic and diluted weighted average common shares used was 56.9M
- Cytori had $40.8M in cash and cash equivalents and $2M in accounts receivable.
